These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 33565819)

  • 1. Prevalence of Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Youth.
    Allan-Blitz LT; Hertlein F; Klausner JD
    Pediatr Infect Dis J; 2021 Mar; 40(3):e132-e133. PubMed ID: 33565819
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Children in a Large Regional US Health System During the Coronavirus Disease 2019 Pandemic.
    Peaper DR; Murdzek C; Oliveira CR; Murray TS
    Pediatr Infect Dis J; 2021 Mar; 40(3):175-181. PubMed ID: 33399431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Among Skilled Nursing Facility Residents and Staff Members-Los Angeles County, August-September 2020.
    Malenfant JH; Eslami M; Dao BL; Moore L; Green N; Silver D; OYong K; Ruparelia A; Fisher R; Wood JS; Faisal M; Washburn F; Shvartsblat S; Jewell MP; Romo T; Foo C; Salazar A; Aguirre S; Balter S; Bhaurla S; Buenrrostro S; Bui K; Cho KY; Chun K; Civen R; Clarke A; Danza P; Fernandes P; Fountas N; Gambon M; Gragnani CM; Griffin A; Guerra L; Guerrero A; Hooshmand K; Claire Jarashow M; Knight W; Kuo AA; Ngo T; Nunez DM; Obara A; Rawson K; Terashita D; Rajagopalan S; Rubin ZA; Gounder P
    J Infect Dis; 2022 Feb; 225(3):367-373. PubMed ID: 34031692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and epidemiological characteristics of SARS-CoV-2 Infection in Los Angeles County youth during the first year of the pandemic.
    Saleh T; Kerin T; Fuller T; Paiola S; Cambou MC; Motwani Y; Newhouse CN; Yang S; Kamau E; Garner OB; Chandrasekaran S; Nielsen-Saines K
    Int J Infect Dis; 2022 Sep; 122():514-520. PubMed ID: 35803467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population.
    Tilley K; Ayvazyan V; Martinez L; Nanda N; Kawaguchi ES; O'Gorman M; Conti D; Gauderman WJ; Van Orman S
    J Adolesc Health; 2020 Dec; 67(6):763-768. PubMed ID: 33071164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.
    Gallichotte EN; Quicke KM; Sexton NR; Fitzmeyer E; Young MC; Janich AJ; Dobos K; Pabilonia KL; Gahm G; Carlton EJ; Ebel GD; Ehrhart N
    Microbiol Spectr; 2021 Dec; 9(3):e0100321. PubMed ID: 34756092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A main event and multiple introductions of SARS-CoV-2 initiated the COVID-19 epidemic in Greece.
    Spanakis N; Kassela K; Dovrolis N; Bampali M; Gatzidou E; Kafasi A; Froukala E; Stavropoulou A; Lilakos K; Veletza S; Tsiodras S; Tsakris A; Karakasiliotis I
    J Med Virol; 2021 May; 93(5):2899-2907. PubMed ID: 33410223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?
    Takahashi S; Greenhouse B; Rodríguez-Barraquer I
    J Infect Dis; 2020 Nov; 222(11):1772-1775. PubMed ID: 32856712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult SARS-CoV-2 infection; a possible hypothesis for viral relapse.
    Elberry MH; Ahmed H
    Med Hypotheses; 2020 Nov; 144():109980. PubMed ID: 32570163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Lower Socioeconomic Status and SARS-CoV-2 Positivity in Los Angeles, California.
    Allan-Blitz LT; Goldbeck C; Hertlein F; Turner I; Klausner JD
    J Prev Med Public Health; 2021 May; 54(3):161-165. PubMed ID: 34092061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Contamination of High-touch Surfaces in Field Settings.
    Gholipour S; Nikaeen M; Mohammadi Manesh R; Aboutalebian S; Shamsizadeh Z; Nasri E; Mirhendi H
    Biomed Environ Sci; 2020 Dec; 33(12):925-929. PubMed ID: 33472732
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 pandemic for Pediatric Health Care: disadvantages and opportunities.
    Praticò AD
    Pediatr Res; 2021 Mar; 89(4):709-710. PubMed ID: 32413890
    [No Abstract]   [Full Text] [Related]  

  • 13. Meet the scientists investigating the origins of the COVID pandemic.
    Mallapaty S
    Nature; 2020 Dec; 588(7837):208. PubMed ID: 33262500
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular biology of coronaviruses: an overview of virus-host interactions and pathogenesis.
    Hidalgo P; Valdés M; González RA
    Bol Med Hosp Infant Mex; 2021; 78(1):41-58. PubMed ID: 33661875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Universal Testing Experience on a Los Angeles Labor and Delivery Unit.
    Naqvi M; Burwick RM; Ozimek JA; Greene NH; Kilpatrick SJ; Wong MS
    Obstet Gynecol; 2020 Aug; 136(2):235-236. PubMed ID: 32433450
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of Genomic Characteristics and Transmission Routes of Patients With Confirmed SARS-CoV-2 in Southern California During the Early Stage of the US COVID-19 Pandemic.
    Zhang W; Govindavari JP; Davis BD; Chen SS; Kim JT; Song J; Lopategui J; Plummer JT; Vail E
    JAMA Netw Open; 2020 Oct; 3(10):e2024191. PubMed ID: 33026453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to
    Nardelli C; Gentile I; Setaro M; Di Domenico C; Pinchera B; Buonomo AR; Zappulo E; Scotto R; Scaglione GL; Castaldo G; Capoluongo E
    Front Cell Infect Microbiol; 2021; 11():625581. PubMed ID: 33659220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures.
    Leuzinger K; Gosert R; Søgaard KK; Naegele K; Bielicki J; Roloff T; Bingisser R; Nickel CH; Khanna N; Sutter ST; Widmer AF; Rentsch K; Pargger H; Siegemund M; Stolz D; Tamm M; Bassetti S; Osthoff M; Battegay M; Egli A; Hirsch HH
    J Med Virol; 2021 Apr; 93(4):2374-2384. PubMed ID: 33314153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019.
    Timberlake DT; Strothman K; Grayson MH
    Curr Opin Allergy Clin Immunol; 2021 Apr; 21(2):182-187. PubMed ID: 33399389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Study of Universal Severe Acute Respiratory Syndrome Coronavirus 2 RNA Testing Among Residents and Staff in a Large Group of Care Homes in South London.
    Marossy A; Rakowicz S; Bhan A; Noon S; Rees A; Virk M; Nazafi A; Hay E; de Thomasson L; Windle C; Zuckerman M
    J Infect Dis; 2021 Feb; 223(3):381-388. PubMed ID: 32889532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.